Enthera

About:

Enthera is a biotech manufacturing company that develops biotherapeutics treatments for underserved auto-immune disorders.

Website: https://www.entherapharmaceuticals.com/

Top Investors: AbbVie, Sofinnova Partners, Indaco Venture Partners, JDRF T1D Fund, Roche Venture Fund

Description:

Enthera is a new Italian biotech start-up whose mission is to find new therapeutic approaches to treat diabetes and related gastrointestinal complication (enteropathy), as well as other intestinal disorders sharing the same biological pathway. Its name comes from the crasis of the terms entero (referring to the intestine) and therapy. Enthera was founded by BiovelocITA in October 2016 in collaboration with the scientists: Prof. Paolo Fiorina and Dr. Francesca D’Addio.